PharmaReports: Cancer Immunotherapy
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel is dedicated to immunotherapy approaches to cancer such as interleukins and other immunostimulators. Oncolytic viruses and cell based therapies are also included in this channel. Most reports included in this channel are technological in approach.
Showing results 151 - 159 of 159
- Acute Lymphocytic Leukemia (ALL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Small Cell Lung Cancer (SCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Malignant Mesothelioma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology
- Non-Hodgkin's Lymphoma (NHL) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Ovarian Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Prostate Cancer - Pipeline Assessment and Market Forecasts to 2020
- Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development